| Event chart GALECTIN THERAPEUTICS INC. |
|
|
|
| Upcoming events on GALECTIN THERAPEUTICS INC. |
|
| 08/15/22 | | Interim 2022 Earnings Release (Projected) |
| 11/15/22 | | Q3 2022 Earnings Release (Projected) |
| 03/30/23 | | FY 2022 Earnings Release (Projected) |
|
| Past events on GALECTIN THERAPEUTICS INC. |
|
| 05/13/22 | | Q1 2022 Earnings Release (Projected) |
| 03/31/22 | 08:00am | | FY 2021 Earnings Release |
| 01/10/22 | 07:00am | | H.C. Wainwright BioConnect Conference |
| 12/03/21 | 11:00am | | Annual General Meeting |
| 11/15/21 | 08:00am | | Q3 2021 Earnings Release |
| 11/12/21 | | AASLD The Liver Meeting |
| 09/13/21 | 07:00am | | H.C. Wainwright Global Investment Conference |
| 08/16/21 | 09:00am | | Interim 2021 Earnings Release |
| 05/17/21 | 08:00am | | Q1 2021 Earnings Release |
| 03/31/21 | 08:00am | | FY 2020 Earnings Release |
|
| Past dividends on GALECTIN THERAPEUTICS INC. |
|
- No events available -
|
|
|
| Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -16,2
-18,6
12% | -13,6
-13,5
-0,69% | -13,4
-11,8
-14% | -23,4
-24,6
4,7% | -30,2
-34,0
11% |
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -16,2
-18,0
9,7% | -13,9
-13,8
-0,62% | -13,3
-11,6
-15% | -23,5
-24,5
4,4% | -30,5
-34,7
12% |
|
Net income
M $ |
Released
Forecast
Spread | -17,5
-18,7
6,6% | -15,0
-14,4
-4,6% | -20,2
-15,0
-34% | -23,6
-24,6
4,1% | -30,7
-34,9
12% |
-34,7
|
EPS
$ |
Released
Forecast
Spread | -0,49
-0,51
3,9% | -0,38
-0,37
-4,1% | -0,39
-0,35
-11% | -0,41
-0,43
4,7% | -0,52
-0,59
12% |
| | Announcement Date | 03/29/2018 | 03/06/2019 | 03/16/2020 | 03/31/2021 | 03/31/2022 | - |
|
|
|
| Fiscal Period : December | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -5,19
-3,48
-49% | -3,58
-5,15
30% | -6,10
-3,80
-61% | -5,93
-8,00
26% | -7,83
-9,00
13% | -6,32
-9,60
34% | -8,19
-10,4
21% | -8,24
-10,2
19% | -7,43
-11,2
34% | -9,94
|
|
|
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -5,14
-3,42
-50% | -3,56
-5,11
30% | -6,11
-3,70
-65% | -5,94
-7,93
25% | -7,85
-8,93
12% | -6,34
-9,55
34% | -8,45
-10,3
18% | -8,52
-10,4
18% | -7,22
-11,4
37% | -9,93
|
|
|
|
Net income
M $ |
Released
Forecast
Spread | -5,20
-3,42
-52% | -3,55
-5,16
31% | -6,18
-3,80
-63% | -5,96
-7,93
25% | -7,92
-8,93
11% | -6,34
-9,55
34% | -8,51
-10,3
18% | -8,56
-10,4
18% | -7,29
-11,5
37% | -9,92
-8,38
-18% |
-8,44
|
-8,91
|
-8,97
|
EPS
$ |
Released
Forecast
Spread | -0,12
-0,06
-100% | -0,06
-0,09
33% | -0,11
-0,07
-57% | -0,10
-0,14
29% | -0,13
-0,16
19% | -0,11
-0,17
35% | -0,15
-0,18
17% | -0,14
-0,18
22% | -0,12
-0,19
37% | -0,17
|
|
|
| | Announcement Date | 03/16/2020 | 05/11/2020 | 08/10/2020 | 11/09/2020 | 03/31/2021 | 05/17/2021 | 08/16/2021 | 11/15/2021 | 03/31/2022 | 05/16/2022 | - | - | - | |
|
|
| Upcoming sector events for GALECTIN THERAPEUTICS INC. |
|
| |
|
| Past sector events for GALECTIN THERAPEUTICS INC. |
|
| |
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year